DAPA HF - The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

1 September 2019 (15:46 - 15:59)
Organised by:
Congress Presentation Part of: Hot Line Session 1 European Society of Cardiology, Other ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by